Sol-Gel is a clinical stage dermatology company focused on identifying, developing, and commercializing topical drug products for the treatment of skin diseases.
We have leveraged our proprietary microencapsulation technology to develop 2 innovative topical formulations under investigation for the treatment of acne and papulopustular rosacea.
©2020 Sol-Gel Technologies Ltd. All Rights Reserved. EPSOLAY and TWYNEO are registered trademarks of Sol-Gel Technologies Ltd. All other trademarks are the property of their respective owners. SOL-2020-004 September 2020
INTRODUCTION
METHODS
ASSESSMENTS
CONCLUSIONS
RESULTS
REFERENCES
Retreatment
RESULTS
Erythema
Patients
X
Rosacea Quality of Life Questionnaire
IGA Success
Safety and Tolerability
CONCLUSIONS
CONCLUSIONS
RESULTS
Reduction in Lesions
HOME
N Bhatia,1 W Werschler,2 H Baldwin,3 J Sugarman,4 L Stein Gold,5 L Green,6 E Lain7
Long-term Efficacy and Safety of Benzoyl Peroxide Cream, 5%, Prepared with Microencapsulation in Papulopustular Rosacea: Results from an Extension of Two Phase 3, Vehicle-controlled Trials
1. Therapeutics Research Inc, San Diego, CA; 2. Spokane Dermatology Clinic and Werschler Aesthetics, Spokane, WA; 3. Acne Treatment & Research Center, Morristown, NJ; 4. University of California - San Francisco, San Francisco, CA; 5. Henry Ford Health Systems, Detriot, MI; 6. Aesthetic Dermatology Center, Rockville, MD; 7. SANIVA Dermatology, Pflugerville, TX
Erythema
Gallery
Rosacea Quality of Life Questionnaire
See Patient Improvement
Over Time
X
Safety and Tolerability
LONG-TERM EFFICACY AND SAFETY OF BENZOYL PEROXIDE CREAM, 5%, PREPARED WITH MICROENCAPSULATION IN PAPULOPUSTULAR ROSACEA: RESULTS FROM AN EXTENSION OF TWO PHASE 3, VEHICLE-CONTROLLED TRIALSEndFragmentEndFragment
1. Therapeutics Research Inc, San Diego, CA. 2. Spokane Dermatology Clinic and Werschler Aesthetics, Spokane, WA. 3. Acne Treatment & Research Center, Morristown, NJ. 4. University of California - San Francisco, San Francisco, CA. 5. Henry Ford Health Systems, Detroit, MI. 6. Aesthetic Dermatology Center, Rockville, MD. 7. SANIVA Dermatology, Pflugerville, TX.
1. Therapeutics Research Inc., San Diego, CA. 2. Spokane Dermatology Clinic and Werschler Aesthetics, Spokane, WA. 3. Acne Treatment & Research Center, Morristown, NJ. 4. University of California - San Francisco, San Francisco, CA. 5. Henry Ford Health Systems, Detroit, MI.
Bhatia, N1, Werschler, W2, Baldwin, H3, Sugarman, J4, Stein Gold, L5
EFFICACY AND SAFETY OF MICROENCAPSULATED BENZOYL PEROXIDE (E-BPO) CREAM, 5% IN PAPULOPUSTULAR ROSACEA: RESULTS FROM TWO PHASE 3, VEHICLE-CONTROLLED TRIALSEndFragmentEndFragment
TWYNEO® (MICROENCAPSULATED BENZOYL PEROXIDE 3%, TRETINOIN 0.1%) PHASE 3 EFFICACY AND SAFETY: RESULTS FROM TWO RANDOMIZED CONTROLLED CLINICAL TRIALS
1. JDR Research, Las Vegas, NV. 2. University of California - San Francisco, San Francisco, CA. 3. Sol-Gel Technologies Ltd, Ness Ziona, Israel
Del Rosso, J1, Sugarman, J2, Levy-Hacham, O3, Mizrahi, R3
REFERENCES
REFERENCES